LOTUSEYEHospital
Lotus Eye Hospital and Institute Ltd — PE Ratio & Valuation Analysis
₹98.22
-2.47%
Current P/E320.93xPrice to earnings
Industry P/E52.84xSector average
4Y Avg P/E53.2x503.8% above avg
⚠️
507.4% Premium to Industry
LOTUSEYE P/E 320.93x vs sector avg 52.84x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2024 | ₹1.40 | ₹67 | 47.6x |
| 2023 | ₹1.96 | ₹83 | 42.6x |
| 2022 | ₹1.44 | ₹77 | 53.2x |
| 2021 | ₹0.75 | ₹52 | 69.2x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Lotus Eye Hospital and Institute Ltd Valuation
Lotus Eye Hospital and Institute Ltd (LOTUSEYE) currently trades at 320.93x earnings. The Hospital sector average PE is 52.84x. LOTUSEYE commands a premium, reflecting high growth expectations. Historically, LOTUSEYE has traded at an average PE of 53.2x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
1.22%
Dividend Yield
0.00%
More on Lotus Eye Hospital and Institute Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.